Mycobacterium szulgai keratitis.
Frueh
B E
BE
Department of Ophthalmology, University of Berne, Switzerland. beatrice.frueh@insel.ch.
Dubuis
O
O
Imesch
P
P
Böhnke
M
M
Bodmer
T
T
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000032:analysis; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007634:Keratitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D008297:Male; D008826:Microbial Sensitivity Tests; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D009170:Nontuberculous Mycobacteria / Q000235:genetics / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D017291:Clarithromycin